Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival
复制标题
DOI:
10.1034/j.1600-6143.2001.10213.x
复制
发表时间:
2001-07-01
影响因子:
8.8
通讯作者:
Abbott, KC
中科院分区:
文献类型:
--
作者:
Batty, DS;Swanson, SJ;Abbott, KC
National statistics for patient characteristics and survival of renal transplant recipients positive for hepatitis C virus (HCV+) at the time of renal transplant are presented.A historical cohort analysis of 33479 renal transplant recipients in the United States Renal Data System from I July, 1994 to 30 June, 1997 has been carried out. The medical evidence form was also used for additional variables, but because of fewer available values, this was analyzed in a separate model. Outcomes were patient characteristics and survival associated with HCV+.Of 28692 recipients with valid HCV serologies, 1624 were HCV+ at transplant (5.7% prevalence). In logistic regression analysis, HCV+ was associated with African-American race, male gender, cadaveric donor type, increased duration of pre-transplant dialysis, previous transplant, donor HCV+, recipient (but not donor) age, serum albumin, alcohol use, and increased all-cause hospitalizations. Diabetes and IgA nephropathy were less associated with HCV+. Total all-cause, unadjusted mortality was 13.1% in HCV+ vs. 8.5% in HCV- patients (p